JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 15, 2005; DOI: 10.1124/jpet.104.080218


0022-3565/05/3133-1289-1295$20.00
JPET 313:1289-1295, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.080218v1
313/3/1289    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oyekan, A. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oyekan, A. O.

CARDIOVASCULAR

Differential Effects of 20-Hydroxyeicosatetraenoic Acid on Intrarenal Blood Flow in the Rat

Adebayo O. Oyekan

Center for Cardiovascular Diseases, College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas

We recently demonstrated that endothelin-1-induced medullary vasodilation despite a potent cortical vasoconstriction in the rat kidney may be accounted for by 20-hydroxyeicosatetraenoic acid (20-HETE) production. This study characterized the effects of 20-HETE and its metabolites, 20-hydroxy prostaglandin E2 (20-OH PGE2) and 20-hydroxy prostaglandin F2{alpha} (20-OH PGF2{alpha}), and the contribution of nitric oxide (NO) and prostanoids to the changes evoked in cortical blood flow (CBF) and medullary blood flow (MBF). We tested the hypothesis that 20-HETE produces qualitatively different regional hemodynamic effects in the kidney with 20-OH PGF2{alpha} or 20-OH PGE2, accounting for the vasoconstriction or vasodilation, respectively, in the cortex and medulla. Renal intra-arterial infusion of 1, 2.5, 5, and 10 ng/min 20-HETE decreased CBF by 10 ± 3, 24 ± 4, 40 ± 7, and 58 ± 9 perfusion units (PU), respectively, but increased MBF by 4 ± 2, 16 ± 4, 27 ± 3, and 41 ± 10 PU, respectively. 20-OH PGF2{alpha} mimics the effects of 20-HETE, as did PGF2{alpha}. However, 20-OH PGE2 increased both CBF and MBF, as did PGE2. Indomethacin (5 mg/kg) blunted the effects of 20-HETE but not that of 20-OH PGE2 and 20-OH PGF2{alpha}. However, SQ29548 ([1S-[1{alpha},2{alpha}(Z),3{alpha},4{alpha}]]-7-[3[[2-[(phenylamino)carbonyl[hydrazino]methyl]-7-oxabicyclo]2.2.1]hept-2-yl]-5-heptenoic acid) (0.1 mg/kg), a prostaglandin H2/thromboxane A2 receptor antagonist, blunted the cortical and medullary hemodynamic effects elicited by 20-HETE, 20-OH PGE2, 20-OH PGF2{alpha}, and PGF2{alpha} but not PGE2. N{omega}-L-nitro arginine methyl ester (5 mg/kg), the inhibitor of NO synthase, exacerbated the cortical constrictor effects of 20-HETE and 20-OH PGF2{alpha} without affecting the medullary perfusion produced by 20-HETE or its metabolites. These findings suggest that 20-HETE, through its hydroxyl metabolites, produced differential effects in the kidney. The medullary perfusion appears to be independent of NO.


Received November 4, 2004; accepted March 14, 2005.

Address correspondence to: Adebayo O. Oyekan, Center for Cardiovascular Diseases, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77004. E-mail: oyekan_ao{at}tsu.edu




This article has been cited by other articles:


Home page
J. Physiol.Home page
Z. Gao, S. Koba, L. Sinoway, and J. Li
20-HETE increases renal sympathetic nerve activity via activation of chemically and mechanically sensitive muscle afferents
J. Physiol., May 15, 2008; 586(10): 2581 - 2591.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G.-H. Kim, N. W. Choi, J.-Y. Jung, J.-H. Song, C. H. Lee, C. M. Kang, and M. A. Knepper
Treating lithium-induced nephrogenic diabetes insipidus with a COX-2 inhibitor improves polyuria via upregulation of AQP2 and NKCC2
Am J Physiol Renal Physiol, April 1, 2008; 294(4): F702 - F709.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C.-J. Liang, H. E. Ives, C.-M. Yang, and Y.-H. Ma
20-HETE inhibits the proliferation of vascular smooth muscle cells via transforming growth factor-
J. Lipid Res., January 1, 2008; 49(1): 66 - 73.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Fang, F. M. Faraci, T. L. Kaduce, S. Harmon, M. L. Modrick, S. Hu, S. A. Moore, J. R. Falck, N. L. Weintraub, and A. A. Spector
20-Hydroxyeicosatetraenoic acid is a potent dilator of mouse basilar artery: role of cyclooxygenase
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2301 - H2307.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.